CN Stock MarketDetailed Quotes
002603 Shijiazhuang Yiling Pharmaceutical
- 15.38
- +0.14+0.92%
Not Open Sep 5 15:00 CST
25.70BMarket Cap92.65P/E (TTM)
15.44High15.22Low69.23KlotVolume15.23Open15.24Pre Close106.32MTurnover0.50%Turnover Ratio19.01P/E (Static)1.67BShares26.9552wk High2.24P/B21.17BFloat Cap14.1652wk Low16.76Limit Up1.38BShs Float53.16Historical High13.72Limit Down1.44%Amplitude4.79Historical Low0.30Dividend TTM15.36Avg Price27.58KlotAsk1.95%Div YieldTTM100Lot Size39.81KlotBid
Shijiazhuang Yiling Pharmaceutical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -35.28%3.88B | -47.46%1.94B | -33.68%9.18B | -0.09%7.43B | 10.53%6B | 47.64%3.69B | 47.36%13.84B | 3.14%7.44B | 13.05%5.43B | -9.99%2.5B |
| Refunds of taxes and levies | -66.65%24.45M | 34.79%10.11M | -71.81%84.5M | -74.82%75.94M | -73.55%73.3M | -45.80%7.5M | 741.21%299.7M | 444.38%301.58M | 1,089.45%277.11M | -11.77%13.84M |
| Cash received relating to other operating activities | -38.64%78.05M | 55.37%44.09M | 57.62%277.81M | 93.23%160.08M | 145.80%127.2M | 48.11%28.38M | -18.74%176.26M | -13.14%82.84M | -37.24%51.75M | -37.09%19.16M |
| Cash inflows from operating activities | -35.72%3.99B | -46.51%1.99B | -33.35%9.54B | -1.99%7.66B | 7.70%6.2B | 47.13%3.72B | 48.43%14.32B | 6.25%7.82B | 17.31%5.76B | -10.29%2.53B |
| Goods services cash paid | -28.20%1.32B | -48.95%605.7M | -27.04%3.42B | 10.36%2.67B | 27.84%1.84B | 100.09%1.19B | 41.53%4.68B | 0.95%2.42B | -15.41%1.44B | -36.73%593.02M |
| Staff behalf paid | -19.53%1.05B | -25.77%553.59M | 7.75%2.23B | 20.20%1.79B | 33.08%1.3B | 48.74%745.76M | 1.10%2.07B | -5.63%1.49B | -7.12%975.76M | -17.36%501.39M |
| All taxes paid | -51.69%536.95M | -59.45%326.96M | -13.17%1.41B | 30.00%1.28B | 47.51%1.11B | 193.29%806.37M | 34.10%1.62B | -0.75%984.28M | -7.68%753.56M | -30.26%274.94M |
| Cash paid relating to other operating activities | -35.53%823.19M | -33.51%387.82M | -5.03%2.34B | 4.54%1.78B | 9.97%1.28B | -5.17%583.29M | -3.76%2.46B | -19.41%1.71B | -29.04%1.16B | -35.14%615.07M |
| Cash outflows from operating activities | -32.59%3.72B | -43.59%1.87B | -13.33%9.39B | 14.01%7.52B | 27.65%5.52B | 67.40%3.32B | 18.79%10.83B | -6.84%6.6B | -16.81%4.33B | -31.25%1.98B |
| Net cash flows from operating activities | -61.18%264.17M | -70.77%117.01M | -95.54%155.46M | -88.18%144.62M | -52.52%680.54M | -26.61%400.34M | 559.69%3.49B | 338.20%1.22B | 593.06%1.43B | 920.46%545.48M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -7.77%1.99B | 57.24%1.47B | 120.39%3.69B | 364.66%2.99B | 614.98%2.16B | --933.49M | 174.10%1.67B | 26.20%643.7M | -40.74%302.25M | ---- |
| Cash received from returns on investments | -38.62%13.09M | 32.03%13.35M | 393.66%37.83M | 1,141.57%21.24M | 1,262.06%21.33M | 2,529.18%10.11M | 22.12%7.66M | -72.68%1.71M | -71.84%1.57M | -8.79%384.66K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -99.42%1.61K | -98.57%1.61K | 175.58%965.96K | 121.19%634.34K | -3.14%278.5K | -54.95%112.4K | -70.74%350.52K | -67.54%286.79K | -64.33%287.52K | 185.11%249.52K |
| Cash inflows from investing activities | -8.09%2.01B | 56.95%1.48B | 121.65%3.73B | 366.61%3.01B | 617.72%2.18B | 148,708.82%943.71M | 172.08%1.68B | 24.85%645.69M | -41.11%304.1M | -99.77%634.18K |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -14.25%104.98M | -41.12%62.83M | 45.26%310.83M | 18.75%208.48M | -2.94%122.42M | 63.09%106.7M | -68.23%213.98M | -62.67%175.56M | -70.74%126.12M | -62.32%65.42M |
| Cash paid to acquire investments | -35.35%1.76B | -41.73%1.34B | 5.09%3.64B | 288.37%3.29B | 672.80%2.73B | 2,199.92%2.3B | 667.52%3.46B | 141.09%846.31M | 0.52%352.85M | -60.13%100.06M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | --676.29M | --628.88M | --499.68M | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -44.22%1.87B | -41.70%1.4B | 25.83%4.63B | 303.59%4.12B | 599.19%3.35B | 1,355.12%2.41B | 226.86%3.68B | 24.41%1.02B | -38.76%478.97M | -61.03%165.48M |
| Net cash flows from investing activities | 111.84%138.12M | 105.28%77.3M | 54.92%-899.22M | -195.41%-1.11B | -566.97%-1.17B | -788.25%-1.46B | -293.64%-1.99B | -23.67%-376.18M | 34.19%-174.86M | -14.45%-164.85M |
| Financing cash flow | ||||||||||
| Cash from borrowing | -23.33%460M | 100.00%400M | -35.13%1.2B | -24.13%1.1B | -29.40%600M | -71.42%200M | -22.92%1.85B | -39.59%1.45B | -57.50%849.9M | 74.98%699.9M |
| Cash received relating to other financing activities | 117.72%217.72M | --80.53M | --500M | -31.48%198.42M | --100M | ---- | ---- | --289.57M | ---- | ---- |
| Cash inflows from financing activities | -3.18%677.72M | 140.26%480.53M | -8.10%1.7B | -25.35%1.3B | -17.64%700M | -71.42%200M | -22.96%1.85B | -27.52%1.74B | -57.50%849.9M | 74.98%699.9M |
| Borrowing repayment | 301.09%601.63M | --401.33M | -70.44%650.3M | -78.13%350M | -89.29%150M | ---- | 49.67%2.2B | 8.85%1.6B | 81.82%1.4B | 700.00%800M |
| Dividend interest payment | -16.43%15.38M | 69.94%7.89M | 208.72%872.77M | 47.69%405.48M | 12.85%18.4M | -49.40%4.64M | -76.83%282.7M | -77.34%274.55M | 55.45%16.31M | 201.68%9.18M |
| Cash payments relating to other financing activities | -26.61%149.58M | -19.48%1.28M | 9,591.21%397.52M | 3,021.39%395.76M | 2,157.57%203.82M | -52.44%1.59M | -68.63%4.1M | --12.68M | --9.03M | --3.34M |
| Cash outflows from financing activities | 105.95%766.6M | 6,487.08%410.51M | -22.77%1.92B | -39.00%1.15B | -73.89%372.22M | -99.23%6.23M | -8.00%2.49B | -29.62%1.89B | 82.63%1.43B | 688.53%812.52M |
| Net cash flows from financing activities | -127.12%-88.88M | -63.86%70.02M | 65.37%-220.59M | 199.54%147.18M | 156.96%327.78M | 272.06%193.77M | -110.83%-637M | 47.52%-147.86M | -147.19%-575.43M | -137.92%-112.62M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -91.68%45.04K | 103.04%5.38K | -73.85%326.4K | -69.73%422.3K | -1.44%541.43K | -109.87%-177.07K | 359.23%1.25M | 793.56%1.39M | 328.69%549.36K | -201.84%-84.37K |
| Net increase in cash and cash equivalents | 299.10%313.45M | 130.37%264.34M | -212.46%-964.03M | -216.81%-819.06M | -123.03%-157.43M | -424.84%-870.35M | 405.38%857.18M | 328.51%701.22M | 3.13%683.55M | 209.67%267.93M |
| Add:Begin period cash and cash equivalents | -53.24%846.63M | -53.24%846.63M | 89.90%1.81B | 89.90%1.81B | 89.90%1.81B | 89.90%1.81B | -22.74%953.48M | -22.74%953.48M | -22.74%953.48M | -22.74%953.48M |
| End period cash equivalent | -29.83%1.16B | 18.15%1.11B | -53.24%846.63M | -40.07%991.6M | 0.99%1.65B | -23.01%940.31M | 89.90%1.81B | 78.44%1.65B | -13.70%1.64B | -7.52%1.22B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Zhongqin Wanxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg